Market Overview

Benzinga's Top #PreMarket Gainers

Related OPHT
Benzinga's Top Initiations
Gabelli Initiates Ophthotech At Buy
Related CLVS
Biotech Enters Reporting Season With Large Caps Central To Sector Performance
Clovis Oncology Initiates Study on CO-1686 - Analyst Blog

Ophthotech (NASDAQ: OPHT) soared 23.97% to $39.00 in the pre-market trading after the company reported that it has entered into an ex-US licensing and commercialization deal with Novartis Pharmaceuticals.

NewLead Holdings (NASDAQ: NEWL) shares jumped 12.82% to $2.20 after surging 209.72% on Monday.

Dendreon (NASDAQ: DNDN) shares jumped 10.28% to $2.36 in pre-market trading after the company announced the presentation of PROVENGE ProACT and IMPACT studies data.

Clovis Oncology (NASDAQ: CLVS) shares climbed 7.45% to $61.00 in the pre-market trading session after the company reported that it has received breakthrough therapy designation for CO-1686.

AstraZeneca PLC (NYSE: AZN) shares gained 1.95% to $72.02 in pre-market trading on investor call for talks with Pfizer (NYSE: PFE).

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (AZN + CLVS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters